loading

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - 0.85 -
Operating Expenses
17.25%
21.07
17.97 12.24 15.89 12.77
Depreciation and Amortization
28.57%
0.10
0.14 0.143 0.152 0.154
Operating Income/Loss
17.25%
-21.07
-17.97 -12.24 -15.04 -12.77
Income/Loss From Continuing Operations Before Tax
19.53%
-19.88
-16.63 -10.48 -13.08 -10.79
Income/Loss From Continuing Operations After Tax
19.53%
-19.88
-16.63 -10.48 -13.08 -10.79
Net Income/Loss
19.53%
-19.88
-16.63 -10.48 -13.08 -10.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.03%
138.28
138.24 137.59 137.59 136.61
Basic Earnings Per Share
16.67%
-0.14
-0.12 -0.08 -0.10 -0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.13
price up icon 1.45%
$84.29
price down icon 0.66%
$25.05
price up icon 0.97%
$102.09
price down icon 0.89%
$135.59
price up icon 0.88%
biotechnology ONC
$300.46
price up icon 0.12%
Kapitalisierung:     |  Volumen (24h):